Fin Trust Capital Advisors, LLC Natera, Inc. Transaction History

Fin Trust Capital Advisors, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$34.17 - $47.91 $14,829 - $20,792	-434 Reduced 77.92%	123 $4,000
Q3 2022 Oct 20, 2022	BUY	$36.93 - $56.68 $5,539 - $8,502	150 Added 36.86%	557 $24,000
Q2 2022 Jul 26, 2022	BUY	$28.13 - $44.54 $4,500 - $7,126	160 Added 64.78%	407 $18,000
Q1 2022 May 03, 2022	BUY	$30.32 - $91.33 $303 - $913	10 Added 4.22%	247 $10,000
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $15,526 - $21,420	-180 Reduced 43.17%	237 $22,000
Q3 2021 Nov 16, 2021	SELL	$100.17 - $126.36 $6,010 - $7,581	-60 Reduced 12.58%	417 $46,000
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $1,032 - $1,436	-12 Reduced 2.45%	477 $54,000
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $9,238 - $12,560	-101 Reduced 17.12%	489 $50,000
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $466 - $782	7 Added 1.2%	590 $59,000
Q3 2020 Nov 10, 2020	BUY	$45.89 - $72.67 $22,945 - $36,335	500 Added 602.41%	583 $42,000
Q2 2020 Sep 11, 2020	BUY	$26.36 - $49.86 $2,187 - $4,138	83 New	83 $4,000
Q2 2020 Aug 14, 2020	SELL	$26.36 - $49.86 $3,136 - $5,933	-119 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$32.1 - $40.4 $64 - $80	2 Added 1.71%	119 $4,000
Q3 2019 Oct 29, 2019	BUY	$25.38 - $34.89 $507 - $697	20 Added 20.62%	117 $4,000
Q2 2019 Aug 01, 2019	SELL	$17.75 - $27.58 $976 - $1,516	-55 Reduced 36.18%	97 $3,000
Q1 2019 May 09, 2019	BUY	$11.34 - $20.62 $748 - $1,360	66 Added 76.74%	152 $3,000
Q4 2018 Feb 11, 2019	BUY	$12.32 - $24.38 $1,059 - $2,096	86 New	86 $1,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.